VCR ventracor limited


  1. 423 Posts.
    Australian biotechnology companies are finding it easier to raise market capital due to investor confidence. Prana Biotechnology has just announced a $A5 million share placement. Prana joins Chemeq, EpiTan, and Ventracor, who have raised funds in recent times. Select Vaccines successfully floated in 2003. It could soon be joined by Alchemia, Cogstate and Acrux. Many companies also have licensing deals with big American pharmaceutical companies like Merck & Company. The rush of private money investment is supported by the Australian Government's new $A150 million Pharmaceutical Partnerships Program.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.